Description:

SOUTHWEST ONCOLOGY GROUP S0221 TRASTUZUMAB USE FORM NCT00070564 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0318EAD1-86F2-752C-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0318EAD1-86F2-752C-E044-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 12/18/14
  2. 1/9/15
  3. 6/12/15
Uploaded on:

June 12, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

SOUTHWEST ONCOLOGY GROUP S0221 TRASTUZUMAB USE FORM NCT00070564

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP S0221 TRASTUZUMAB USE FORM
    1. No Instruction available.
Header
Trastuzumab Use Assessment
HER-2/neu status
Marker Test Method
When was trastuzumab given?
Cardiovascular Examination
%
Symptomatic CHF
Method of Evaluation
Method of determination
Comments